WEKO3
アイテム
Overvirw of Carbon Ion Radiotherapy at NIRS
https://repo.qst.go.jp/records/54182
https://repo.qst.go.jp/records/541829e8618bb-a2fe-45e7-b906-9e1be9444ba1
| Item type | 会議発表論文 / Conference Paper(1) | |||||
|---|---|---|---|---|---|---|
| 公開日 | 2009-11-16 | |||||
| タイトル | ||||||
| タイトル | Overvirw of Carbon Ion Radiotherapy at NIRS | |||||
| 言語 | ||||||
| 言語 | eng | |||||
| 資源タイプ | ||||||
| 資源タイプ識別子 | http://purl.org/coar/resource_type/c_5794 | |||||
| 資源タイプ | conference paper | |||||
| アクセス権 | ||||||
| アクセス権 | metadata only access | |||||
| アクセス権URI | http://purl.org/coar/access_right/c_14cb | |||||
| 著者 |
Tsujii, Hirohiko
× Tsujii, Hirohiko× 辻井 博彦 |
|||||
| 抄録 | ||||||
| 内容記述タイプ | Abstract | |||||
| 内容記述 | The world-first clinical center offering carbon ion radiotherapy (C-ion RT) was set to open in 1994 at NIRS, Japan, using HIMAC. Among several types of ion species, carbon ions were chosen for cancer therapy because they were judged to have the most optimal properties in terms of superior physical and biological characteristics. As of January 2009, a total of 4,494 patients have been registered for C-ion RT. Clinical results have shown that C-ion RT has the potential ability to provide a sufficient dose to the tumor, together with acceptable morbidity in the surrounding normal tissues. Tumors that appear to respond favorably to carbon ions include locally advanced tumors as well as those with histologically non-squamous cell types of tumors such as adenocarcinoma, adenoid cystic carcinoma, malignant melanoma, hepatoma, and bone and soft tissue sarcoma. By taking advantage of the unique properties of carbon ions, treatment with small fractions within a short treatment period has been successfully carried out for a variety of tumors | |||||
| 書誌情報 |
NIRS-ETOILE Joint Symposium on Carbon Ion Radiotherapy 巻 NIRS-M, 号 218, p. 10-19, 発行日 2009-03 |
|||||
| 出版者 | ||||||
| 出版者 | National Institute of Radiological Sciences | |||||
